The UK government announced that it is partnering with BioNTech to trial personalised cancer vaccines.
Academic rigor, journalistic flair
Articles on BioNTech
Displaying all articles
Moves by Moderna and BioNTech to make vaccines themselves in African countries signal that the companies aren’t considering licensing its technology to a third party for local manufacture.
The type of deep-tech ventures behind mRNA vaccines are key to economic prosperity and sustainable development.
With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.
The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.
Because Pfizer-BioNTech and Moderna vaccines have been developed in record time, many wonder whether companies cut corners or compromised safety.
There are two new COVID-19 vaccines that appear to be more than 90% effective. But what are these vaccines, and how are they different from those used previously?
Interim analysis of trial data isn’t unusual – but leaves us with many things we still need to find out.
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
Top contributors
-
Professor of Technology Management, University of Pretoria
-
Clinical Associate Professor of Pharmacy Practice, Binghamton University, State University of New York
-
Professor of Medicine, University of Virginia
-
Professor of Molecular and Cell Biology, University of California, Merced
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Lecturer in Entrepreneurship, Innovation and Organisational Design, RMIT University
-
Senior Lecturer in Biochemistry and Cell Biology, University College Cork
-
Instructor of Human Immunology, Emory University
-
Professor of Pharmacy and Pharmaceutical Sciences, Binghamton University, State University of New York
-
Professor of Biomedical Sciences, Anglia Ruskin University
